
Anil Kumar Vyas
About Anil Kumar Vyas
Data last updated:
Anil Kumar Vyas is a Director at Mednext Biotech Limited (since 2017), Director at Alice Pharma Private Limited (since 2010) and Director at Ceza Formulations Private Limited (since 2014), and holds 2 more current directorships. The companies operate in Pharma and Financial Services. The 5 current companies with reported revenue have a combined latest revenue of ₹67.68 Cr; the largest is Mednext Biotech Limited at ₹36.86 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Oct 2017 | 2012 | ₹36.86 Cr (FY 2025) | Active | |
| Director | 25 Nov 2010 | 2006 | ₹21.91 Cr (FY 2025) | Active | |
| Director | 13 Dec 2014 | 1999 | ₹3.60 Cr (FY 2024) | Active | |
| Director | 13 Sep 2021 | 2021 | ₹2.75 Cr (FY 2024) | Active | |
| Director | 03 Feb 2009 | 2009 | ₹2.56 Cr (FY 2024) | Active |
Board colleagues of Anil Kumar Vyas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Neelam Vyas | 02435581 | Mednext Biotech Limited , Alice Pharma Private Limited and 2 more | Director |
| Shriansh Vyas | 07575641 | Mednext Biotech Limited | Director |
| Alex Charles Fernandes | 02417576 | Alice Pharma Private Limited | Director |
| Leena Alex Fernandes | 01566227 | Alice Pharma Private Limited | Director |
| Krishnakant Mundra | 06988783 | Ceza Formulations Private Limited | Director |
| Mimoh Paliwal | 06988784 | Ceza Formulations Private Limited | Director |
| Narendra Kumar Dalawat | 07508806 | Ceza Formulations Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Kumar Vyas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Kumar Vyas
Anil Kumar Vyas currently holds 5 directorships: Mednext Biotech Limited (Director, since 10 Oct 2017, revenue ₹36.86 Cr (FY 2025)); Alice Pharma Private Limited (Director, since 25 Nov 2010, revenue ₹21.91 Cr (FY 2025)); Ceza Formulations Private Limited (Director, since 13 Dec 2014, revenue ₹3.60 Cr (FY 2024)); Tirtham Hospitality Private Limited (Director, since 13 Sep 2021, revenue ₹2.75 Cr (FY 2024)); Mednext Pharma Private Limited (Director, since 03 Feb 2009, revenue ₹2.56 Cr (FY 2024)).
Anil Kumar Vyas was first appointed on 03 Feb 2009 as Director at Mednext Pharma Private Limited. The most recent appointment on record is 13 Sep 2021 at Tirtham Hospitality Private Limited.
The 5 current companies of Anil Kumar Vyas that report revenue have a combined latest revenue of ₹67.68 Cr: Mednext Biotech Limited ₹36.86 Cr (FY 2025); Alice Pharma Private Limited ₹21.91 Cr (FY 2025); Ceza Formulations Private Limited ₹3.60 Cr (FY 2024); Tirtham Hospitality Private Limited ₹2.75 Cr (FY 2024); Mednext Pharma Private Limited ₹2.56 Cr (FY 2024).
The current boards of Anil Kumar Vyas's companies include Neelam Vyas (Mednext Biotech Limited), Shriansh Vyas (Mednext Biotech Limited), Alex Charles Fernandes (Alice Pharma Private Limited), Leena Alex Fernandes (Alice Pharma Private Limited), Krishnakant Mundra (Ceza Formulations Private Limited), Mimoh Paliwal (Ceza Formulations Private Limited), among others.